REG - Competition and Mkts - Merger Update: Stryker/Cerus

StrykerAnnouncement

17/04/2023 10:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230417:nRSQ1139Wa&default-theme=true

RNS Number : 1139W  Competition and Markets Authority  17 April 2023

Merger Clearance:

 

The CMA has decided on the information currently available to it, not to refer
the following merger to a Phase 2 investigation under the provisions of the
Enterprise Act 2022:

 

ANTICIPATED ACQUISITION BY STRYKER CORPORATION OF CERUS ENDOVASCULAR LIMITED

 

The text of this decision will be placed on the Competition and Markets
Authority's website at  https://www.gov.uk/cma-cases
(https://www.gov.uk/cma-cases) as soon as is reasonably practicable.

 

In the event of media enquiries, please email Press@cma.gov.uk
(mailto:Press@cma.gov.uk) or call on 020 3738 6460.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MERGPUWCCUPWUMW